Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 4522
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3616
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GU
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Daniel.J. George Susan Halabi Andrew B. Nixon Mark D. Starr J.Chris Brady Herbert I. Hurwitz Ian Barak M. Morris Brian.I. Rini Eric Small Won Kim Mary-Ellen Taplin
- Networks:
- CA136, LAPS-MA036, LAPS-NC007, LAPS-NC010, LAPS-NY016, TN008
- Study
- CALGB-90206
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: